Rheumnow Podcast

Dr. Jack Cush reviews the news, journal articles and RNL highlights from this past week on RheumNow.com

This is a replay from the live RNL 2023 meeting and session on SPONDYLOARTHRITIS INNOVATIONS held on March 19, 2023. This POD (session) devoted to advances in Spondyloarthritis and featured three excellent lectures: - Dr. Atul Deodhar – Five Advances in SpA - Dr. Denis Poddubnyy - Evaluation of the SI Joint - Dr. John Reveilee – A Family Hx of AS – what does it mean This Spondyloarthritis Innovations session was sponsored by Lilly

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week we delve into some odd associations, repeat drug warnings and the consequences of antirheumatic therapies.

Audience questions from the live RNL 2023 meeting and the session on EVOLUTION AND ADVANCES IN VASCULITIS held on March 18, 2023. These sessions were sponsore by Sanofi. This POD (session) featured three excellent lectures: - Dr. Robert Spiera: Therapies for GCA and PMR - Dr. Anisha Dua: Assessment of GCA and PMR - Dr. Carol Langford: GPA Treatment Choices

This week on the Podcast Dr. Jack Cush reviews the news and journal articles, including the risks of dying, developing RA or autoimmune disease!

Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A: Remission in Psoriatic Arthritis Laura Coates, MBBS University of Oxford JAK inhibitors in Psoriasis and PsA Eric Ruderman, MD Northwestern University Feinberg School of Medicine Pregnancy in PsA Christina Chambers, PhD, MPH

This week on RheumNow.com featuring Dr. Jack Cush

Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A: Preclinical RA – To Treat or Not To Treat Kevin Deane, MD University of Colorado Year of the JAKi Stanley Cohen, MD, University of Texas Southwestern Medical School Fibroblast/Stromal Cells Michael Brenner, MD Brigham and Women’s Hospital Harvard Medical School

Tune in as rheumatologists Dr. Christina Charles-Schoeman and Dr. Roy Fleischmann discuss how you can help mitigate cardiovascular risk in your patients with rheumatoid arthritis. Listen as they share their perspectives on the rheumatologist’s role in cardiovascular risk assessment, patient education, and maintaining a primary focus on patient disease control.

This podcast presented by Dr. Michelle Petri, Professor of Medicine at the Hopkins Lupus Center, describes how estimated glomerular filtration rate slope may be a valid surrogate endpoint for monitoring renal damage accrual in lupus nephritis. 1 1. Levey AS et al. Am J Kidney Dis. 2020;75(1):84–104.

Dr. Jack Cush reviews the news and journal reports and addresses 3 viewer case questions.

Town Hall - Creating Change Join us as we conclude our Women in Rheumatology campaign by focusing on what's next. Our panelists will recap the major challenges addressed this month and discuss a strategy to continue supporting women in rheumatology. Speakers: Dr. Kathryn H. Dao, MD Dr. Rachel Tate, DO Dr. Gwenesta B. Melton, MD Moderator: Jack Cush, MD

This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.

Private Practice & Academia In this session, our panelists will address the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". Strategies for self-promotion, networking, finding a mentor, and engaging in research will be discussed with opportunities for you to ask the panelists questions about how you can advance in your career. Speakers: Dr. Priya Reddy, MD, FACR Dr. Grace C. Wright, MD Dr. Sheetal Desai, MD Dr. Maio Danila, MD Moderator: Dr. Kathryn H. Dao, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, including Rheumatology success in the NRMP MATCH, Cocaine vasculitis and worrisome safety risks with Biologics and tsDMARDs.

April 11, 2023 Contract Negotiations Our panelists are joined this week by Andrea Liberatore, JD, to discuss contract negotiations. Join us to learn more about initial contracts, renegotiating contracts, and working with pharma. You will have a chance to ask our panelists questions and learn how to approach your next contract negotiation. Speakers: Gwenesta B. Melton, MD, FACR Andrea Liberatore, JD, is a member of the Litigation team. Her practice encompasses litigation matters for businesses, individuals, and local government Moderator: Dr. Kathryn H. Dao, MD

Dr. Jack Cush reviews the news and highlights from our "Women in Rheumatology" Campaign from last week on RheumNow.com

Tuesday - April 4, 2023 Straddling career and family obligations can be challenging at all stages of your career and family life. Our panelists will discuss the challenges they have faced and provide advice and strategies for managing competing priorities and obligations. Speakers: Dr. Marcela Ferrada Dr. Yvonne Sherrer Dr. Una Makris Moderator: Dr. Rachel Tate

Dr. Jack Cush reviews the CV advantage to walking, the OA risk with running and the eczema-OA connection; these articles and journal reports from the past week on RheumNow.com

Dr. Jack Cush reviews the news and journal articles from the past 2 weeks on RheumNow.com. This week reviews clinical associations with SS-A, a new biomarker for SSc-ILD and cancer screening for myositis patients.

Drs. Artie Kavanaugh and Jack Cush discuss upcoming lectures and highlights at RNL23

QD213 - My Bum Knee https://www.youtube.com/watch?v=zJWMlNjwvLE QD214 - New PMR Paradigm https://www.youtube.com/watch?v=chMOQb1FDUY QD215 - Abdominal Pain, Arthralgias, and a Poor Diet https://www.youtube.com/watch?v=XpYZ75aEt6o QD216 - Gottrons Without Weakness https://www.youtube.com/watch?v=S8ObCFHCtpw QD217 - Weight Loss & PsA https://studio.youtube.com/video/P9wsdrEURmQ/edit QD218 - RheumNow Live 2023 Preview https://youtu.be/gVJ1XxsQ2WQ

Dr. Jack Cush Reviews the News and Journal articles from the past week on RheumNow. This weeks highlights includes insights on scleroderma, myositis, vasculitis and answers the question - does aggressive biologic treatment of psoriasis prevent future psoriatic arthritis?

QD209 - Recurrent Fevers; 3 Days at 103F https://youtu.be/whOxV89bKoQ QD210 - Double Positive, but Few Joints https://youtu.be/HxW012E4K2U QD211 Managing Septic Arthritis in RA https://youtu.be/K39sPOBTSII QD212 - I Wanna Get Pregnant https://youtu.be/52ydswdTvG8

Dr. Jack Cush reviews the lastest journal articles, news, and FDA announcements from the past week on RheumNow. This week, the importance of IFNa, Subclinical PsA and NSAID safety during Pregnancy.

QD205 - Chest Pain & Fever https://youtu.be/uw3V5NQTYTM QD206 - Arthralgia, Raynaud's & Anemia https://youtu.be/PUmQYDXayBc QD 207 - Molly's in trouble https://youtu.be/vIFTTqIxwsE QD 208 - VTE Options https://youtu.be/ZPyioVr7RQE

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Dr. Jack Cush reviews the news and tries to stump the expert panel this week on the podcast.

Dr. Jack Cush reviews the news, journal articles and the numbers, from the past week on RheumNow.com

Dr. Jack Cush reviews the past week of news on RheumNow.com

Dr. Jack Cush reviews this weeks journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything

Dr. Jack Cush reviews the highlights from the past week on RheumNow.com

Dr. Jack Cush reviews the notable standouts in the news since the 1st of January. Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.

Dr. Jack Cush Reviews the highlight from 2022 in Rheumatology Check out the full podcast at RheumNow.com

Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.

ACR22 Year in Review Report Deucravacitinib in PsA JAK inhibitors in rheumatic diseases JAK vs TNF inhibitor Infections in RA New Treatments for SLE? Prelude to a Meeting (ACR22) (11.11.2022) Switching Between JAK Inhibiters in RA Tapering Methotrexate with Biologics or JAK Inhibitors in RA Tofacitinib and RA-ILD Upadacitinib vs Adalimumab in PsA using RAPID3

Addressing Sexual Health and STD Prevention in Lupus Patients CAR-T Therapies in Antiphospholipid Antibody Syndrome Copays Reduce Adherence to SLE Medications Diffuse alveolar hemorrhage in antiphospholipid syndrome Hydroxychloroquine Update from ACR22 Low-grade Proteinuria in Non Renal Lupus: Should We be Worried? Photovoice: A New Visual Research Method in Lupus Stop Ordering Repeat ANAs! Timely Fetal Screening Important in Positive Anti-Ro Antibody Pregnancies Life or Organ Threatening SLE: What To Do? Is There Anything New?

ACR22 Daily Recap: Saturday Recap New Treatments for SLE?

A Novel Treatment Response Measurement Tool for Lupus ACR22 Year in Review Report Breakthrough COVID infection in SLE during Omicron era Effect of voclosporin in class V lupus nephritis Lupus, Sex and STDs Poor Medication Adherence in SLE and How to Improve It Prelude to a Meeting (ACR22) (11.11.2022) Should You Repeat the ENA Panel? Urinary Biomarkers in Lupus Urine Proteomics in SLE with Dr. Michelle Petri

Sunday (Day 2): ACR 22 Daily Recap

ACR 2022 Appraisal, Praise & Critique (11.18.2022) Best of ACR Day Two in PSA Efficacy and Safety Results from BE OPTIMAL in PsA JAK inhibitors in rheumatic diseases Oligoarticular PsA: FOREMOST Study Opioid use in PsA and SpA PET CT Imaging to Define Risk of Progression from PSO to PsA PsA and SPA: Cyclers, Switchers, Who is the Winner? Switch vs Cycle in PsA Women vs. Men: Response to Treatment in Seronegative Arthritis

Best of PsA on Day 1 Can computers tell the difference between RA & PsA? Deucravacitinib in PsA Differences in Presentation and Outcomes of Early vs Late Onset PsA Opioids and Health Care Utilization in PsA and AS Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor PsA Cycling or Switching MOAs The Dietary Intervention in PsA (DIPSA) Study Ultrasound in PsA Upadacitinib vs Adalimumab in PsA using RAPID3

Sunday (Day 2): ACR 22 Daily Recap

Bouncebackability portends increased risk of adverse outcomes in RA Can I stop Methotrexate in RA? Fat and bone are never alone: osteoporotic fracture in RA JAK inhibitors in rheumatic diseases RA: Steroids are bad, again Reproductive health in a post-Roe world Sensor-engineered glove evaluates hand function in RA Tapering Methotrexate with Biologics or JAK Inhibitors in RA Tofacitinib and RA-ILD

ACR22 Daily Recap: Saturday Recap JAK vs TNF inhibitor Infections in RA Opioid and Neuropathic Use After Initiating btsDMARDs in RA Pre-RA Pharmacological Interventions: Delaying is not Enough PreRA to Treat or Not! Prescribing Methotrexate in Post-Roe Era The Great Debate: To Treat or Not to Treat Pre RA To Switch or Not: Biosimilars in Inflammatory Arthritis

ACR22 Year in Review Report Can computers tell the difference between RA & PsA? NSAIDs and CV risk in Inflammatory Arthritis Prelude to a Meeting (ACR22) (11.11.2022) QD205 - RA Activity During Pregnancy (abstract #0955) Sputum anti-CCP the new diagnostic test in at-risk RA? Switching Between JAK Inhibiters in RA Treatment Choices and Mortality in RA ILd

Treatment Considerations in Axial Spondyloarthritis What Happens after you stop biologics? What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Which is better for AxSpA? IL-17i or TNFi? Women vs. Men: Response to Treatment in Seronegative Arthritis